Silco Pharmaceuticals Limited
  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • New Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Dividend Compliance Report
    • Dividend Disbursement Policy
    • Unpaid/Unclaimed Dividend
    • Prospectus
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us
Select Page

Shop

Showing 73–84 of 231 results

  • Calcium & Combinations

    Calcium & Combinations

  • Calcium Carbonate , Vitamin D3

    Calcium Carbonate , Vitamin D3

  • Carbonyl Iron INN, Folic Acid , ZnSO4.H2O

    Carbonyl Iron INN, Folic Acid , ZnSO4.H2O

  • Cefixime Trihydrate

    Cefixime Trihydrate

  • Cefixime Trihydrate (Comp.)

    Cefixime Trihydrate (Comp.)

  • Cefuroxime Axetil

    Cefuroxime Axetil

  • Cefuroxime Axetil

    Cefuroxime Axetil

  • Cefuroxime Axetil, Diluted Clavulanate Potassium with Avicel

    Cefuroxime Axetil, Diluted Clavulanate Potassium with Avicel

  • Cefuroxime Axetil, Diluted Clavulanate Potassium with Avicel

    Cefuroxime Axetil, Diluted Clavulanate Potassium with Avicel

  • Cefusil CV 250 Tablet

    Cefusil CV 250 Tablet

  • Cefusil CV 500 Tablet

    Cefusil CV 500 Tablet

  • Cefusil-250 Tablet

    Cefusil-250 Tablet

  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 18
  • 19
  • 20
  • →

Registered & Head Office

Nurani-41, Ban-Kalapara, Subid Bazar, Sylhet-3100, Bangladesh.

Phone: +8802996638241

E-mail:  info@silcopharma.com

 

 

 

 

 

 

 

 

 

 

 

 

 

ABOUT US

  • Home
  • About Us
  • Products
    • Product Catalogue
  • Facilities
  • Investor
    • Notice
    • Annual Report & Audited Accounts
    • New Annual Report & Audited Accounts
    • Half Yearly Reports
    • Quarterly Reports
      • First Quarter Accounts ended Sep. 30, 2025
    • Price Sensitive Information (PSI)
    • Code of Conduct
    • Dividend Compliance Report
    • Dividend Disbursement Policy
    • Unpaid/Unclaimed Dividend
    • Prospectus
    • TT clean rate
    • Utilization Report
  • Global Operations
  • Contact Us

PRODUCTS

  • By Trade Name
  • By Generic Name
  • By Therapeutic Class

FACILITIES

  • Quality Policy
  • Manufacturing Facility
  • Quality Assurance
  • HVAC system
  • Cephalosporin Unit
  • Wastewater Treatment
  • Facebook
  • Twitter
  • Google
  • Youtube
  • RSS
© Silcopharma 2024 || Designed and Develop by Momi Technology LLC